ArticleJournal of plant research2026
Overexpression of the tomato SlLEA_2-26 gene enhances the tolerance to drought and salt stresses in Arabidopsis thaliana.
Article in Journal of plant research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
Late embryogenesis abundant (LEA) proteins are pivotal in conferring cellular tolerance to abiotic stresses and sustaining plant growth and development. However, systematic functional characterization of the tomato SlLEA_2 gene family remains limited. To elucidate the role of tomato SlLEA_2-26 in abiotic stress responses, this study cloned its full-length cDNA. Quantitative real-time PCR (qRT-PCR) analysis revealed that SlLEA_2-26 exhibits predominant expression in flowers and fruits, and is strongly induced by drought, salt, Cu
Indexed as
Identifiers
42295662What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.